Cisco's (NASDAQ: CSCO) stock recently rallied after the networking giant posted its third-quarter numbers. Will its high yield and low valuation make Cisco a safe-haven stock for a turbulent market? Let's dig deeper to see whether investors should chase its post-earnings rally
Gold is a volatile commodity prone to swift and dramatic price swings, but it often does well when other investment options are souring. Because of this fact, investors often like to have a small amount of gold exposure in their portfolios to increase diversification. If that so
Airlines have been hit hard by the COVID-19 pandemic, sending stocks crashing down and causing Warren Buffett to run for the emergency exits. Airlines today are trading at valuations that suggest they might not survive, and many prominent industry watchers are worried they migh
The coronavirus pandemic continues to have a huge impact on the entire world. In the U.S. alone, more than 86,000 people have died, tens of millions of people have lost their jobs, and many more are watching helplessly as their financial reserves dwindle and run out. To help wit
Nike's (NYSE: NKE) share price still remains 10% below January and early February's low-$100 range even after sharply recovering from the coronavirus market crash that caused the stock to plummet to late March's low-$60 level. Granted, it is hard to push out this noise, but long
Just two months ago, the stock market was in free fall due to fear about the impact of the COVID-19 pandemic. The S&P 500 index plunged 35% between mid-February and late March. That represented the deepest bear market since the Great Recession.
In March, legislators passed the CARES Act, a massive stimulus package designed to help American households pay their bills through the coronavirus-fueled economic crisis. The CARES Act will ultimately cost $2.2 million, an alarming price tag for a federal government that's alre
On Friday, Clovis Oncology (NASDAQ: CLVS) gained Food and Drug Administration approval of Rubraca for patients with metastatic castration-resistant prostate tumors that have BRCA mutations.
A month has gone by since the last earnings report for Morgan Stanley (MS). Shares have lost about 2.8% in that time frame, underperforming the S&P 500.
It has been about a month since the last earnings report for Sonoco (SON). Shares have lost about 4.9% in that time frame, underperforming the S&P 500.
It has been about a month since the last earnings report for Badger Meter (BMI). Shares have lost about 1.5% in that time frame, underperforming the S&P 500.
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
Read the news, and you'll see staggering numbers on the jobless front. The unemployment rate reached an all-time high of 14.7% in April, and while employees of all ages have been impacted by the COVID-19 crisis, older workers have been hurt to an alarming degree.
The unpredictable nature of the market makes it difficult to foresee where any stock will trade five years from now. However, Verizon (NYSE: VZ) may offer more visibility than other stocks.
The recent earnings presentations from Raytheon Technologies (NYSE: RTX) served to highlight the investment case for the stock. In a nutshell, its commercial aerospace operations are facing very significant headwinds in 2020 and it's not going to be a V-shaped bounce back. Howev
The last couple of months have been a wild ride for the majority of Americans, with the coronavirus pandemic wreaking havoc on our society. The stock market has also been hit hard, with both the Dow Jones Industrial Average and S&P 500 experiencing one of their worst quarter
LexinFintech Holdings (NASDAQ: LX), a leading fintech company in China, has seen its share price decline 47% from its January peak this year. The negative sentiments and lack of understanding toward China's fintech industry, as well as the recent COVID-19 outbreak, drove the co